SUSQUEHANNA INTERNATIONAL GROUP, LLP - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$12,939,114
-22.5%
720,842
-12.4%
0.00%
-50.0%
Q2 2023$16,704,407
+76.5%
822,472
+58.5%
0.00%
+100.0%
Q1 2023$9,466,924
+16.9%
519,020
+32.5%
0.00%0.0%
Q4 2022$8,100,563
-1.0%
391,710
+25.2%
0.00%
-33.3%
Q3 2022$8,185,000
-15.5%
312,901
-18.1%
0.00%0.0%
Q2 2022$9,683,000
+13.9%
382,127
+41.9%
0.00%
+50.0%
Q1 2022$8,501,000
-13.6%
269,351
+10.8%
0.00%
Q4 2021$9,838,000
+110.8%
243,054
+81.7%
0.00%
Q3 2021$4,666,000
-22.1%
133,787
-38.7%
0.00%
Q2 2021$5,993,000
+41.9%
218,254
+45.1%
0.00%
Q1 2021$4,223,000
-42.0%
150,408
-46.4%
0.00%
Q4 2020$7,278,000
+96.9%
280,434
+30.1%
0.00%
Q3 2020$3,696,000
+39.4%
215,627
+101.2%
0.00%
Q2 2020$2,651,000
+1340.8%
107,158
+428.6%
0.00%
Q3 2019$184,000
-22.7%
20,271
-32.1%
0.00%
Q2 2019$238,00029,8420.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders